Protagonist Therapeutics (PTGX) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Protagonist Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
May 7, 2020 4:31 PM EDTNEWARK, Calif., May 7, 2020 /PRNewswire/ --Â Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today reported its financial results for the first quarter ended March 31, 2020, and provided an update on clinical development programs.
